Gross Profit Comparison: Walgreens Boots Alliance, Inc. and Pharming Group N.V. Trends

Pharmaceutical Giants: A Decade of Profit Trends

__timestampPharming Group N.V.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 20142159516521569000000
Thursday, January 1, 2015659042726753000000
Friday, January 1, 20161176854229874000000
Sunday, January 1, 20179258703829162000000
Monday, January 1, 201812920384330792000000
Tuesday, January 1, 201916541244728159000000
Wednesday, January 1, 202020305643026077000000
Friday, January 1, 202116967007128067000000
Saturday, January 1, 202218806000028266000000
Sunday, January 1, 202322010400027072000000
Monday, January 1, 202426524000000
Loading chart...

Unleashing the power of data

A Tale of Two Giants: Walgreens Boots Alliance vs. Pharming Group

In the ever-evolving pharmaceutical landscape, Walgreens Boots Alliance, Inc. and Pharming Group N.V. have showcased contrasting trajectories in gross profit over the past decade. From 2014 to 2023, Walgreens Boots Alliance consistently demonstrated robust financial health, with gross profits peaking at approximately $30.8 billion in 2018. Despite a slight dip in 2023, their profits remained strong, reflecting their resilience in a competitive market.

Conversely, Pharming Group N.V. experienced a remarkable growth journey, with gross profits surging by over 900% from 2014 to 2023. This growth underscores their strategic advancements and market penetration. However, the absence of data for 2024 leaves room for speculation on future trends.

This comparison not only highlights the diverse strategies of these industry players but also offers insights into the dynamic nature of the pharmaceutical sector.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025